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Abstract 
Background: The RNA guided CRISPR/Cas9 nucleases have been proven to be effective for gene disruption in vari-
ous animal models including Xenopus tropicalis. The neural crest (NC) is a transient cell population during embryonic 
development and contributes to a large variety of tissues. Currently, loss-of-function studies on NC development in 
X. tropicalis are largely based on morpholino antisense oligonucleotide. It is worthwhile establishing targeted gene 
knockout X. tropicails line using CRISPR/Cas9 system to study NC development.
Methods: We utilized CRISPR/Cas9 to disrupt genes that are involved in NC formation in X. tropicalis embryos. A sin-
gle sgRNA and Cas9 mRNA synthesized in vitro, were co-injected into X. tropicalis embryos at one-cell stage to induce 
single gene disruption. We also induced duplex mutations, large segmental deletions and inversions in X. tropicalis by 
injecting Cas9 and a pair of sgRNAs. The specificity of CRISPR/Cas9 was assessed in X. tropicalis embryos and the Cas9 
nickase was used to reduce the off-target cleavages. Finally, we crossed the G0 mosaic frogs with targeted mutations 
to wild type frogs and obtained the germline transmission.
Results: Total 16 target sites in 15 genes were targeted by CRISPR/Cas9 and resulted in successful indel mutations 
at 14 loci with disruption efficiencies in a range from 9.3 to 57.8 %. Furthermore, we demonstrated the feasibility of 
generation of duplex mutations, large segmental deletions and inversions by using Cas9 and a pair of sgRNAs. We 
observed that CRISPR/Cas9 displays obvious off-target effects at some loci in X. tropicalis embryos. Such off-target 
cleavages was reduced by using the D10A Cas9 nickase. Finally, the Cas9 induced indel mutations were efficiently 
passed to G1 offspring.
Conclusion: Our study proved that CRISPR/Cas9 could mediate targeted gene mutation in X. tropicalis with high 
efficiency. This study expands the application of CRISPR/Cas9 platform in X. tropicalis and set a basis for studying NC 
development using genetic approach.
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Background
The neural crest (NC) is a unique cell population that are 
pluripotency and highly migratory, and can differentiate 
into a large variety of cell types including the peripheral 
nervous system and facial skeletons. During embryonic 
development, the NC specification, migration and dif-
ferentiation are tightly regulated by a sophisticated reg-
ulatory network [1]. The NC development has been 
intensively studied using various animal models includ-
ing the Xenopus embryos, however, currently loss-of-
function assay for studying NC development in Xenopus 
embryos are largely based on the knockdown approach of 
morpholino antisense oligonucleotides. Therefore, gen-
eration of gene knockout genetic model of Xenopus will 
provide new insights on NC development.
Precise and efficient genome editing by engineered 
endonucleases is considered as a powerful reverse genetic 
approach to facilitate the study of gene functions and to 
establish disease models. The currently available genome 
editing tools of engineered endonucleases like Zinc Fin-
ger Nucleases (ZFNs) and Transcription Activator-Like 
Effector Nucleases (TALENs) have enabled relatively fast, 
specific genome targeting across human cells and various 
model organisms [2–9]. In addition, the newly emerged 
platform based on the type II clustered regularly inter-
spaced short palindromic repeats (CRISPR) system offers 
a RNA-guided DNA recognition platform over the cur-
rent protein based platforms of ZFNs and TALENs for 
genetic manipulation because of its convenience and easy 
access features [10–13]. This bacterial based adaptive 
immune system consists of two short RNAs, tracrRNA 
and crRNA, and a single protein Cas9. The tracrRNA and 
crRNA can be fused as one single guide RNA (sgRNA) 
for a functional CRISPR system in a previous study [12]. 
The commonly used Cas9 is derived from Streptococ-
cus pyogenes (hereafter, Cas9 refers to the spCas9). The 
target sequence of Cas9 can be any 20 bp sequence fol-
lowed by NGG, a conserved protospacer adjacent motif 
(PAM) [11, 13], which restricts the S. pyogenes Cas9 tar-
get space to every eight base pairs on average. By now, 
the CRISPR systems have been shown to disrupt specific 
targets effectively in various cell lines and organisms [11, 
14–26]. Co-injection of more than one custom sgRNAs 
with Cas9 mRNA demonstrated multiplexed gene dis-
ruption in mouse embryonic stem cells [27], zebrafish 
[27, 28] and X. tropicalis [26]. Recently, human tumor-
associated chromosomal translocation was also achieved 
by applying Cas9 and a pair of sgRNAs targeting two 
chromosomes [29]. In addition to genome editing, the 
CRISPR/Cas9 platform with small modifications have 
been successfully transformed into tools to knockdown 
gene expression [30, 31], to create engineered transcrip-
tion activator or repressor [32, 33], and more recently, 
to visualize repetitive elements in telomeres and coding 
genes in living cells [34].
As a novel tool for genome editing, the specificity of 
CRISPR/Cas9 received increasing attentions, as it is criti-
cally essential for future therapeutic applications and bio-
logical studies. Recent studies reported obvious off-target 
effects of CRISPR/Cas9 occurred in human cell lines [35–
37], whereas, other studies with mouse embryos, mouse 
embryonic stem cell and X. tropicalis embryos suggested 
that CRISPR/Cas9 induced off-target effect was at a low 
rate [27, 38, 39].
D10A is a Cas9 nickase in which the 10th Asp in the RuvC 
catalytic domain is converted to Ala. Using D10A together 
with a pair of sgRNAs targeted to complementary strands 
of a target site could also induce indel mutations and was 
reported to decrease the off-target effect notably [36].
In this study, we utilized Cas9 paired with sgRNAs to 
disrupt genes that mainly involved in NC development 
in X. tropicalis embryos. We have designed 16 sgRNAs 
targeting 15 genes that are involved in NC specification, 
differentiation and migration. Among them, 14 sgRNAs 
are effective, showing the gene disruption rate from 9.3 
to 57.8  %. We demonstrated simultaneous targeting of 
duplex genes in X. tropicalis embryos. We indicated that 
CRISPR/Cas9 system could induce segmental deletion and 
reversion in somatic cells. Although the Cas9 showed high 
specificity in most tested loci, we observed obvious off-
target effects when we targeted sox9 locus. We then used 
Cas9 D10A nickase and a pair of sgRNAs to reduce the off-
target cleavages. Our studies shed light on the design and 
optimization of the CRISPR/Cas9 system for genome edit-
ing in X. tropicalis embryos, and set up a basis to study NC 
development using knockout X. tropicalis.
Results
Disruption of gene involved in neural crest development 
by using CRISPR/Cas9
The CRISPR/Cas9 has been proven to be effective for gene 
disruption (Fig. 1a). We therefore want to use this approach 
to generate genetic models that can be used for studying NC 
development. We designed sgRNA targeting the involved 
in NC development using the guideline as we previous 
reported [26, 40], and the schematic drawing was shown in 
Fig. 1b. Total 16 loci from 15 different genes were selected 
for targeting (Fig.  1; Additional file  1: Figure S1). We co-
injected 500  pg Cas9 mRNA and 40  pg sgRNA to obtain 
single gene disruption with high mutagenesis rate as we 
tested previously [26]. Forty-eight hours after injection, we 
randomly pooled five embryos injected with Cas9/sgRNA, 
extracted genomic DNA, amplified the targeted region, ana-
lyzed cleavage efficiency with T7E1 assay. The representa-
tive T7E1 gel images and calculated disruption efficiency 
were shown in Fig.  1c and d, respectively. We found that 
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Cas9 can efficiently induce gene disruption, resulting in the 
cleavage efficiency from 9.3 to 57.8  %. The Cas9-induced 
indel mutations were confirmed by sequencing (Fig.  1e; 
Additional file 1: Figure S1).
Representative phenotypes induced by CRISPR/Cas9 in G0 
frogs
High disruption efficiency could imply the knockout 
phenotype even at G0 frog [9, 41]. Disruption of pax3 
caused the pigmentation defects at limbs revealed by 
lack of pigments and more transparent skin (7 out of 
7), and severe defects of paralyzed upper limbs (3 in 7), 
which resembled some symptoms of Waardenburg syn-
drome in human [42] (Additional file 1: Figure S2A–D). 
Another example is the disruption of tyrosinase [43, 44]. 
The Tyrosinase converts tyrosine into pigment melanin, 
therefore disruption of tyr in X. tropicalis embryo will 
cause loss of pigments in larvae, which can be easily dis-
cerned. The partial albinism was also observed in adult 
G0 frogs (3 in 3) (Additional file 1: Figure S2E, F).
Fig. 1 Single gene disruption targeting genes involved in NC development in X. tropicalis embryos. a Schematic diagram of sgRNA-guided Cas9 
nuclease interacting with the DNA target site. The red letters indicate the target site, the green letters indicate the PAM and the blue letters indicate the 
sequence of tracer RNA. b Schematic drawing of Cas9 target site (protospacer). The protospacer adjacent motif (PAM) 3′ to the protospacer is high-
lighted in red. The seed region which consists of 12 nucleotides immediate 5′ to PAM is shown in blue. c T7E1 assay of somatic mutations induced by 
pax3, snai1, ctnnb, sox9, or Ap2α sgRNAs and Cas9 nuclease. d Somatic mutation rate calculated from T7E1 assay in (c). e DNA sequences targeted 
by sgRNAs at the indicated gene loci and representative somatic mutations induced in X. tropicalis embryos. PAM is underlined and highlighted in 
green. Deleted sequences are highlighted in gray with red dashes while insertions are indicated by lowercase letters in blue. The parentheses enclosed 
the number of deleted or inserted base pairs, while the square brackets show the frequencies of the mutation in the sequenced samples
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Duplex gene disruptions induced by Cas9
A biological process usually was controlled by a group 
of genes. Loss-of-function may not be achieved by just 
disruption of a single gene as redundant members from 
the same gene family may exert complimentary function. 
Therefore multiplex gene disruption is valuable for study-
ing the hierarchy of a gene regulatory network. During 
the NC specification, Pax3 and Zic1 coordinate to induce 
expression of NC specific transcription factors. We 
injected mixture of pax3 sgRNA, zic1 sgRNA and Cas9 
mRNA into X. tropicalis embryos. At 48 hpf, genomic 
DNA was extract from single embryo, and the locus spe-
cific PCR detected that mutations were induced at both 
pax3 and zic1 loci in 10 out of 10 embryos. T7E1 assay 
indicated mutation rates were 5–23 % for pax3, and 0.9–
32  % for zic1. Sequencing data confirmed the somatic 
mutations induced by duplex sgRNAs (Fig. 2a–c).
We targeted snail1 and snail2 simultaneously with 
the same strategy. Again we found both snail1 and 
snail2 were disrupted in single embryos. Five out of five 
embryos harboring mutation at snail1 and snail2 loci, 
with mutation rate 3–40.5 % for snail1 and 1–7.4  % for 
snail2 revealed by T7E1 assay. It is notable that mutagen-
esis rates calculated from sequencing data were higher 
than those obtained from T7E1 assay. Eight out of 20 
and five out of 20 colonies derived DNA from embryo #4 
harbor mutation in the loci pax3 and zic1, respectively. 
Similarly, Sequencing results indicated higher mutagen-
esis rate for snail2. Three out of 19 colonies derived from 
embryo #2 harbored indel mutations (Fig. 2d–f).
Targeted segmental deletion and inversions
Although CRISPR/Cas9 with a single sgRNA could 
induce indel-mutations with high frequency, such indel-
mutations are often small (<30  bp). This particular fea-
ture cannot satisfy requirements where larger and more 
predictable genomic alterations are desired. Genera-
tion of large segmental deletion is very useful to study 
the functions of noncoding elements, such as lincRNA, 
miRNA clusters and cis-regulatory modules. It is also val-
uable to make animal models for the diseases caused by 
the segmental deletions [45] or by chromosomal inver-
sions [46]. The ability to create large segmental deletion 
or inversion is therefore very useful for generating animal 
models or cell lines for studying human diseases. To test 
whether CRISPR/Cas9 can efficiently induce segmental 
deletion or inversion in Xenopus embryos, we designed 
another sgRNA that targeted to 3′ UTR in pax3, pax3 T2 
sgRNA, which is approximate 40  kb downstream of the 
pax3 sgRNA (hereafter pax3 T1 sgRNA) targeting site 
(Fig.  3a). We injected the mixture of pax3 T1 sgRNA, 
pax3 T2 sgRNA and Cas9 into embryos at one-cell stage. 
Ten injected embryos were pooled and genomic DNA 
was extracted at 48 hpf. The possible large segmental 
deletions were detected by PCRs with primers that can 
bridge two targeting sites (Fig. 3b). The amplicons were 
subcloned to TA vector, and the mutations were con-
firmed by sequencing (Fig. 3c). The generation of inver-
sion induced by this pair of sgRNAs was also detected by 
PCR by using two forward primers from each targeting 
sites separately (Fig.  3b) and confirmed by afterwards 
sequencing (Fig. 3c). Similarly, we also created segmental 
deletion and inversion at snail1 loci using a pair of sgR-
NAs which target snail1 5′ UTR and exon 3 respectively 
(hereafter snail1 T1 and snail1 T2 sgRNAs). The segment 
between the two snail sgRNA targeting sites is 2.5  kb. 
Co-injection of snail T1, snail1 T2 sgRNAs and Cas9 also 
induced segmental deletion and inversion revealed by 
PCR assay, and then confirmed by sequencing (Fig. 3d). 
Thus CRISPR/Cas9 system is an effective tool to generate 
segmental deletions or inversions in Xenopus embryos, 
which set a basis for generating Xenopus models for dis-
eases caused by segmental deletion or inversion.
Gene disruption with sgRNA designed with 5′‑NAG‑3′ PAM 
sequence
A recent study that investigated gene regulation mediated 
by engineered Cas9 transcriptional activator suggested 
that Cas9 can also use 5′-NAG-3′ as an alternative PAM 
[33]. To test whether it is feasible for Cas9-mediated gene 
disruption in X. tropicalis embryos, we designed three 
sgRNAs targeting id3, myosinX, and twist1 immediately 
followed by 5′- NAG-3′, respectively. We tested their 
efficacy in X. tropicalis embryos by injecting 40 pg NAG 
sgRNA with 500  pg Cas9 mRNA into embryos at one-
cell stage. As revealed by T7E1, these targeting induced 
mutagenesis efficiencies at 1.2 % for id3, 3.9 % for myosin 
X, and 0  % for twist1 (Additional file  1: Figure S3). We 
amplified the target regions, TA cloned the amplicons, 
and sequenced the colonies for each of gene. None indel 
mutations were identified, which confirmed our observa-
tion with T7E1 assay. The low mutagenesis rates suggest 
that the 5′- NAG-3′ is not an effective PAM sequence for 
Cas9 in X. tropicalis embryos.
Assess the potential CRISPR/Cas9 off‑target effects 
in Xenopus embryos
Although CRISPR/Cas9 platform is an effective tool for 
genome editing, some studies with cultured cell lines 
indicated obvious off-targets of CRISPR/Cas9 at some 
loci [35–37]. However, other studies in mouse embryonic 
stem cells or X. tropicalis embryos suggested high spe-
cificities of CRISPR/Cas9 at the tested loci [38, 39]. The 
CRISPR/Cas9 mediated specific DNA cleavage can be 
significantly reduced by single mismatch at the sgRNA 
target sites [11, 47], especially in the seed region (12 
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Fig. 2 Duplex indel mutations in single embryo. a, d T7E1 assay of duplex indel mutations in the loci of pax3 and zic1 (a) or snail1 and snail2 (d) in 
five single embryos. b, e Quantification of the T7E1 assay in (a) or (d). c, f Representative sequencing data confirmed the indel mutations induced at 
the two target loci in one single embryo
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nucleotides located in the 3′ next to PAM, Fig.  1b). We 
also scanned X. tropicalis genome to identify potential 
off-target sites for the 16 targeted loci, and found the 
potential off-target sites corresponding to 11 target loci 
(Additional file  1: Table S3). These potential off-target 
loci from the targeted embryos were amplified by locus 
specific PCR, and the amplicons were analyzed by T7E1 
assay. Totally, 25 potential off-target loci correspond-
ing to the 11 target loci were analyzed by T7E1 assay, 
and 11 off-target loci showed T7E1 positive (Fig. 4). We 
selected the loci with over 10  % mutagenesis rate, and 
subcloned the amplicons into PMD-18T vectors. Five 
to eleven bacterial colonies for each off-target loci were 
randomly picked for sequencing. Two potential off-tar-
get sites, sox9-579 and lrig3-E306 were failed in T7E1 
analysis, since no clear and specific bands after T7E1 
assay were detected due to repetitive sequences in the 
region. Although T7E1 assay suggested obvious off-tar-
get mutagenesis at Ap2α-963 (50  %), sox9-826 (15.4  %), 
and zic1-645 (32 %) loci, sequencing data did not reveal 
Fig. 4 Off-target effects of CRISPR/Cas9 in X. tropicalis evaluated via T7E1 assay. a Representative gel image of T7E1 digested off-target amplicons. 
The percentage under panels indicated the frequencies of off-target effects. b Quantification of the cleavage frequencies of all off-target sites. No 
clear and specific bands after T7E1 assay were generated at sox9-579 and lrig3-E306 loci. The cutting efficiencies at sox9-579 and lrig3-E306 sites were 
calculated by sequencing results. Red dash line indicated 10 % in indels efficiency
(See figure on previous page.) 
Fig. 3 Segmental deletions and inversions induced by Cas9 and a pair of sgRNAs in X. tropicalis embryos. a Schematic diagram showing the struc-
ture of X. tropicalis pax3 and snail1 genes, and the sgRNA targeting sequences and their locations in the two genes. b Schematic diagram illustrating 
detection of segmental deletion and inversion at targeted loci with PCR. c, d PCR assay and subsequent sequencing detected segmental deletions 
and inversion at pax3 locus (c) and snail1 locus (d). The embryos injected with Cas9 and indicated sgRNAs were collected at 2 days after fertiliza-
tion. Five embryos were pooled for DNA extraction. T1, embryos injected with Cas9 mRNA and sgRNA T1; T2, embryos injected with Cas9 mRNA and 
sgRNA T2; T1 + T2, embryos injected with mixture of Cas9 mRNA, sgRNA T1 and sgRNA T2. F forward primer; R reverse primer
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any mutations at these loci (Additional file  1: Figure 
S4). However, off-target mutagenesis induced at other 
examined loci was profound. Among them, mutations 
were found in all the sequenced samples at five exam-
ined loci (sox9-600, sox9-766, sox9-794, sox9-807, and 
sox9-815). The sequence variations occurred at ets1-302 
were proven as nucleotide polymorphism because the 
uninjected embryos also harbors the same DNA alter-
nations (Additional file  1: Figure S4). Collectively, these 
results indicated that CRISPR/Cas9 could induce obvi-
ous mutagenesis at some off-target loci in X. tropicalis 
embryos.
D10A nickase reduced off‑target cleavage in Xenopus 
embryos
Recent reports indicated the off-target mutations 
induced by Cas9 in cultured cell lines [11, 35–37]. We 
also observed substantial off-target effects when we 
used Cas9 to target sox9 locus. Since the high specific-
ity is essential for genome editing, we next sought to find 
approaches to minimize off-target effect of CRISPR/
Cas9. The two nuclease domains in Cas9, HNH and 
RuvC, cleave the DNA strand complementary and non-
complementary to the sgRNA, respectively. Point muta-
tion of D10A in RuvC or H840A in HNH converted Cas9 
into DNA nickases [11, 12]. Recent studies with cultured 
mammalian cells indicated that off-target effects can be 
significantly reduced by using D10A nickase with a pair 
of sgRNAs targeting both strands [36]. We therefore test 
the efficiency of this approach in X. tropicalis embryos 
at pax3 and ets1 loci. First, we tested whether the D10A 
approach can induce gene disruption in X. tropicalis 
embryos. We designed a sgRNA against pax3 at the 5′ 
upstream of the previous target site (pax3 T3 sgRNA). 
The offset of the sgRNA pair (pax3 T1 and pax3 T3) is 
+5 bp, while the 5′ overhang is 42 bp (Additional file 1: 
Figure S5A). We injected D10A Cas9 mRNA together 
with pax3 sgRNA pairs into the X. tropicalis embryos at 
stage one and detected the mutation efficiency by direct 
sequencing (Additional file 1: Figure S5B). The mutation 
efficiency induced by nickase was comparable to wild 
type Cas9 (36.8 vs 47.1 %). Similarly, we designed another 
sgRNA targeting ets1 (ets1 T2). The offset of sgRNA pairs 
is +64  bp. Co-injection of Cas9 mRNA and the pair of 
ets1 sgRNAs induced indel mutations as well with ratio of 
5.3 % (Additional file 1: Figure S5C, D).
The sox9 sgRNA/Cas9 can induced indel mutation at 
sox9 locus as well as the off-target sites at sox9-600, sox9-
766, sox9-794, sox9-807, and sox9-815 (Fig. 4; Additional 
file 1: Figure S4). We designed another sgRNA targeting 
sox9 locus at 9 bp 5′ upstream to the sox9 sgRNA target-
ing site (sox9 T2), both of which will generate 43  bp 5′ 
overhang (Fig. 5a).
We injected D10A mRNA together with sox9 T1 and 
sox9 T2 sgRNAs into X. tropicalis embryos, and exam-
ined the on-target indel mutation by T7E1 and direct 
sequencing. The indel mutation ratio is 32.6  % (T7E1 
data not shown), which is lower than we obtained with 
wild type Cas9/sox9 T1 sgRNA (Fig. 5b). We next exam-
ined the effects of this configuration on the off-target 
sites. Revealed by direct sequencing, the ratio of muta-
tion at sox9-600 locus was reduced from 50 to 10 %, sug-
gesting D10A nickase can reduce the off-target efficiency 
in X. tropicalis (Fig. 5c–f).
Cas9‑induced mutagenesis is highly heritable
The Cas9 targeted embryos were raised to sexual matu-
rity, and crossed with wild type frogs. We collected 
embryos, extracted DNA from single embryos and used 
T7E1 assay to determine whether the embryos harbored 
mutations. T7E1 assay indicated that one embryo from 
one founder male frog of zic1, and three embryos from 
two founder male frogs of pax3, snail1 and id3, respec-
tively, carried the induced mutations. Such mutations 
were further confirmed by sequencing. So the rate of 
germ line transmission of the mutations ranged from 5 to 
22 % (Additional file 1: Figure S5). The data again indicate 
that sgRNA/Cas9-induced mutagenesis is highly herit-
able. We are in the progress of establishing the knockout 
lines using the approach we described previously [48].
Discussion
In this study, we utilized CRISPR/Cas9 platform to dis-
rupt genes involved in NC development. In addition to 
the single gene disruption, we also successfully generated 
duplex and segmental gene disruptions. After evaluation 
of off-target effects in X. tropicalis embryos, we found 
that the Cas9 D10A nickase approach can reduce off-
target cleavage. Our studies add versatility to this pow-
erful tool for genome editing in X. tropicalis embryos. 
With improving the specificity, this simple and highly 
versatile tool will greatly expand our capacity on biologi-
cal researches.
Currently, most laboratories utilize Cas9 from S. pyo-
genes for genome editing, and select 5′-N20-NGG-3′ 
sequence as its targeting sites (Fig.  1b). Based on this 
finding, the chance for designing sgRNA is 1/8 in a given 
genome. We have successfully targeted 14 genes that 
involved in NC formation, migration and differentiation 
using this approach, and will continue to establish knock-
out X. tropicalis lines step by step. We observed some 
phenotypes from G0 frogs and showed the representatives 
in Additional file 1: Figure S2. It should be mentioned that 
the G0 frogs are mosaic, and G0 phenotypes could lead to 
adverse effects to their progeny as well. The G0 frog phe-
notype may provide some hints for the gene function. The 
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Fig. 5 Double-nicking induced efficient genome editing with lower off-target effects. a Two sgRNA targeting sites in sox9. Letters in blue is the 
target site 1 while letters in red is the target site 2. The red arrows point the predicted cleavage sites, and the PAMs are underlined. b Sequencing data 
of the indels induced by D10A and the sgRNA pairs. Letters in bold is the wild type sequence, red dashes indicate deletions. c T7E1 assay of genome 
editing induce by wide-type Cas9 or by D10A. d Quantification of the T7E1 assay shown in (c). e Mutagenesis at a representative off-target locus 
(sox9-600) induced by Cas9 and sox9 T1gRNA or by D10A and sox9 T1 and T2 sgRNAs. PCR was performed to amplify the targeted sox9-600 locus. 
Amplicons harboring targeted gene fragments were TA-cloned into pMD-18T. The indel mutagenesis rates were calculated by direct sequencing. (f) 
Comparison of the off-target efficiency induced by D10A with double nicking versus wide type Cas9 with sox9 sgRNA
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gene knockout phenotype can only be determined after 
the knockout line is established, and we should know and 
distinguish these two kinds of phenotypes.
In addition, recent report suggested that 5′-NAG-3′ 
can also serve as PAM for Cas9. We tested three targeted 
sites that were followed by NAG at twist1, myosin X and 
id3 loci, respectively, none of them can be disrupted 
(Additional file  1: Figure S3). Our data suggested that 
NAG cannot serve as an effective PAM for Cas9, at least 
in X. tropicalis embryos.
Multiplex mutations at different loci can be simulta-
neously induced in one embryo by co-injection of Cas9 
mRNA and a combination of corresponding sgRNAs 
[26]. The NC specification was regulated by combined 
effects of pax3 and zic1 [49]. The two transcription fac-
tors of snail1 and snail2 play important roles in epithe-
lial-mesenchymal transition of NC development [50, 51]. 
We used Cas9 induced duplex somatic mutations at pax3 
and zic1 loci, and snail1 and snail2 loci in X. tropicalis 
embryos (Fig. 2). Generation of large segmental deletion 
is very useful for studying the function of non-coding 
DNA sequences or regulatory DNA elements. It can be 
also used for deletion of a particular protein domain to 
study gene functions. Our data indicated that CRIPSR/
Cas9 is efficient to generate large segmental deletion/
inversions. Such abilities make CRISPR/Cas9 system a 
very useful platform for functional studies and for gen-
eration of diseases models.
In our pilot gene disruption studies with CRISPR/Cas9, 
we did not identified obvious off-target effects at some 
gene loci [26]. However, with increasing number of gene 
loci tested by CRISPR/Cas9, we found off-target in some 
gene loci (Fig.  4 and Additional file  1: Figure S4). Most 
off-target loci we identified are located in non-coding 
region and even intergenic region, which may not affect 
normal development even indel mutations were induced 
in these regions. We suggest 10 % T7E1 rate as a cut-off 
for further evaluation of the off-target cleavages. The 
off-target cleavages with low mutagenesis rate could be 
diluted through backcross with wild type animals.
The paired D10A approach can be a good solution to 
minimize the potential off-target effects induced by Cas9. 
In line with previous research work, we also observed the 
off-cleavages were reduced about five times when we tar-
geted sox9 locus with D10A and a pair of sgRNAs (sox9 
T1  +  T2 sgRNAs) compared to those induced by wild 
type Cas9 and sox9 sgRNA (Fig. 5). The design of sgRNA 
pairs followed the principles described previously. Briefly, 
the offsets between the sgRNA pairs are less than 100 bp, 
and ideally from −4 to 20 bp; and the sgRNA pair should 
generate a 5′ overhang other than 3′ overhang. The 
sgRNA pairs fulfill the above conditions may generate 
indel mutants.
Our criteria for identification of potential off-target 
sites seem reliable. A previous report indicated that even 
two mismatches to sgRNA were well tolerated by Cas9 to 
induce DNA cleavages at some loci, while three or more 
mismatches can significantly reduce the mutagenesis 
capacity [35]. Our criteria allow three mismatches, which 
could cover most of the potential off-target sites.
A few strategies may reduce the potential off-target 
cleavage induced by Cas9. (1) Use Cas9 D10A nickase 
coupled with a pair of sgRNAs to reduce potential off-
targets. (2) Reduce injection doses of Cas9 mRNA and 
sgRNA which may decrease the possible mis-binding of 
sgRNA to the off-target sites, or if possible, select another 
sgRNA binding site. A study suggests that the off-target 
effects occur as sequence dependent [52]. (3) Perform 
BLAST search, and avoid homologous sequences to 
reduce the possible off-target binding of gRNAs [53]. (4) 
Utilize the dCas9-FokI approach that was reported to 
reduce the off-target cleavage [54].
Taken together, we used CRISPR/Cas9 to induce indel 
mutations at gene loci involved in NC development in X. 
tropicalis, and set a basis for studying this developmen-
tal process using genetic animal models. When com-
pared with the other two genome editing tools, ZFN and 
TALEN, the CRISPR/Cas9 platform is simpler and more 
convenient. Modified CRISPR/Cas9 platform with high 
specificity will have great impacts on biomedical research 
and treating human diseases.
Conclusion
The NC cells are highly pluripotent that can differentiate 
into a large variety of cell derivatives. Many congenital 
birth defects are due to abnormalities of NC develop-
ment. While Xenopus has been utilized as an ideal model 
to study the NC development, currently loss-of-function 
assay in Xenopus embryos are largely based on the MOs 
knockdown approach, which is hurdled by its transient 
effects. In this study, we took advantages of CRISPR/Cas9 
system to induce targeted gene mutations in X. tropica-
lis embryos. We designed sgRNAs targeting 16 loci in 
15 genes, 14 of which could induce indel mutations with 
relatively high efficiency. We generated duplex muta-
tions and large fragment deletions or inversions using 
this system as well. The off-target effects of this system 
in X. tropicalis embryos was carefully evaluated, and we 
showed evidence that the Cas9 D10A nickase approach 
can reduce off-target cleavage.
Our studies proved CRISPR/Cas9 system as a powerful 
genome editing tool in X. tropicalis embryos. By crossing 
with the wild type frogs, we obtained the G1 heterozy-
gotes harboring mutations. We can utilize this platform 
to study the functions of the genes involved in NC devel-
opment in future.
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Methods
All experimental protocols were approved by The Gov-
ernment of the Hong Kong Special Administrative 
Region, Department of Health. The methods were car-
ried out in accordance with the approved guidelines.
X. tropicalis maintenance and husbandry
The X. tropicalis was purchased from Nasco Co. (USA), 
and the frog maintenance in principle followed the Har-
land X. tropicalis Website (http://tropicalis.berkeley.edu/
home/). Synchronized embryos were obtained by in vitro 
fertilization using method describe previously [9, 48].
DNA constructs
The human codon-usage optimized Cas9 constructs were 
created by Church’s lab and purchased from Addgene 
(Cat. No. 41815). pCS2-Cas9-NLS was generated by 
inserting Cas9 ORF coding sequence and relative SV40 
T-antigen nuclear location signal (NLS) into pCS2 + vec-
tor. The pCS2-Cas9-2NLS was constructed by inserting 
two NLS together with Cas9 coding sequence [26].
The sgRNA sequences were designed by using web-
based program ZiFiT Targeter Version 4.2 (http://zifit.
partners.org/ZiFiT/). Two oligonucleotides with the 
targeting sequence containing BsaI cutting sites at 5′ 
end were annealed first, and the annealed oligonucleo-
tides were cloned into sgRNA vector pDR274 (Addgene 
#42250) [55] after BsaI digestion. The oligo sequences for 
sgRNA constructs were shown in Additional file 1: Table 
S1.
Preparation of Cas9 mRNA and sgRNA for microinjection
The pCS2-Cas9-NLS and pCS2-Cas9-2NLS were lin-
earized by NotI (NEB), respectively. Cas9 mRNAs were 
transcribed with mMESSAGE mMACHINE SP6 Kit (Life 
Technologies, Ambion) using linearized Cas9 constructs 
as template. The Cas9 mRNAs were purified using RNA 
purification kit (QIAgen) and eluted in RNase-free water. 
The sgRNAs were transcribed with T7 RNA polymer-
ase after linearization of sgRNA constructs by DraI, and 
purified with mirVana miRNA Isolation kit (Life Tech-
nologies, Ambion).
Microinjection
The mixture of Cas9 mRNA and sgRNAs as indicated 
in the figures were injected into X. tropicalis embryos at 
one-cell stage. Microinjection was followed as previous 
studies [9, 48]. The injected embryos were collected for 
DNA extraction at 48 h after fertilization.
T7 endonuclease 1 (T7E1) assay
T7E1 assay was basically performed as previously 
described [26, 56]. Briefly, 150–200  ng amplicons were 
denatured and re-annealed in 19  μl digestion solution 
using the following program: 95  °C for 5 min, 95–85  °C 
at −2 °C/s, 85–25 °C at −0.05 °C/s, and then maintained 
at 4  °C. The annealed DNA samples were digested with 
T7E1 (NEB M0302L), and then separated by 1.5 % aga-
rose gel. DNA was visualized by GelRed staining. DNA 
signals were quantified using ImageJ software (http://
rsb.info.nih.gov/ij/). The PCR primers for T7E1 assay 
to detect on-target cleavages were shown in Additional 
file 1: Table S2.
Determination of mutagenesis rate
We normally utilize T7E1 assay to determine the 
mutagenesis rate. However, T7E1 can give false positive 
at some gene loci due to the repetitive segments or nucle-
otide polymorphism in X. tropicalis genome. We used 
direct sequencing to determine the mutagenesis rate 
(colonies harboring mutations/total colonies) in case the 
T7E1 assay seems not reliable.
Identification of potential off‑target sites in X. tropicalis
Potential off-target sites were identified in X. tropicalis 
genome based on the following criteria, (1) tolerate up to 
three mismatches in the sgRNA-DNA interface sequence 
(protospacer); (2) only allow one mismatch in the seed 
region (12 nucleotides 5′ to the PAM); (3) PAM is the 
5′-NGG-3′ motif and the N represents four nucleotides. 
The potential off-target sites were amplified by PCR using 
genomic DNA extracted from Cas9/sgRNA injected 
embryos. Amplicons were either digested by T7E1 assay 
or subcloned into TA cloning vector for sequencing. The 
off-target cleavages were confirmed by DNA sequenc-
ing. The PCR primers for T7E1 assay to detect off-target 
cleavages were shown in Additional file 1: Table S4.
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